Related Experiment Video
Updated: Jul 13, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
Enhancement of a TH1 immune response in amphotericin B-treated mucocutaneous leishmaniasis
Washington R Cuna1, Rianed Velasquez, Janeth Riva
1Department of Pathology, Faculty of Medicine, University Mayor de San Andrés, La Paz, Bolivia.
Abstract:
In an attempt to investigate the effects of treatment of human leishmaniasis, the cytokines produced by peripheral blood mononuclear cells (PBMCs) of patients with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) under treatment with amphotericin B were determined during the active disease from cocultures of cells and Leishmania (Viannia) braziliensis antigens. PBMC of these patients exhibited a nonsignificant marginal increased production of TNF-alpha upon antigen stimulation. However, under the same antigenic stimulus, patients with active MCL presented higher IFN-gamma production compared to patients with CL. This increased IFN-gamma production was accompanied by a drastically augmented IL-12 synthesis from cells of MCL patients. The highlighted T cell responses could be relevant for sound control measures of protozoan infections with emphasis on the combined usage of immunoenhancing agents and antiprotozoal drugs.
Related Concept Videos
Antiprotozoal Agents
Leishmaniasis
Antifungal Agents
Cryptococcal Meningitis
